Protagonist Therapeutics, Inc.
PTGX
$155.10
$3.682.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 782.58M | 547.79M | 567.36M | 576.12M | 570.47M |
| Total Receivables | 19.64M | 57.12M | 4.50M | 5.33M | 27.97M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.62M | 3.99M | 5.71M | 4.98M | 4.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.31M | 4.56M | -- | -- | -- |
| Total Current Assets | 807.15M | 613.46M | 577.57M | 586.42M | 602.53M |
|
|
|||||
| Total Current Assets | 807.15M | 613.46M | 577.57M | 586.42M | 602.53M |
| Net Property, Plant & Equipment | 10.40M | 11.17M | 11.69M | 12.27M | 12.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.12M | 288.00K | 287.00K | 287.00K | 290.00K |
| Total Assets | 885.54M | 697.46M | 668.19M | 701.69M | 718.01M |
|
|
|||||
| Total Accounts Payable | 3.46M | 8.44M | 5.34M | 5.65M | 3.25M |
| Total Accrued Expenses | 21.49M | 16.99M | 28.08M | 22.68M | 15.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.40M | 2.34M | 2.28M | 2.23M | 2.17M |
| Total Finance Division Other Current Liabilities | 9.83M | 6.78M | 9.74M | 14.39M | 14.85M |
| Total Other Current Liabilities | 9.83M | 6.78M | 9.74M | 14.39M | 14.85M |
| Total Current Liabilities | 37.18M | 34.55M | 45.44M | 44.94M | 35.51M |
|
|
|||||
| Total Current Liabilities | 37.18M | 34.55M | 45.44M | 44.94M | 35.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.82M | 7.44M | 8.04M | 8.52M | 9.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 2.79M | 5.38M |
| Total Liabilities | 44.00M | 41.99M | 53.48M | 56.25M | 49.99M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.12B | 1.08B | 1.07B | 1.05B |
| Retained Earnings | -304.04M | -466.89M | -470.67M | -426.29M | -386.95M |
| Treasury Stock & Other | -828.00K | -269.00K | 641.00K | 525.00K | -15.00K |
| Total Common Equity | 841.54M | 655.47M | 614.71M | 645.44M | 668.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 841.54M | 655.47M | 614.71M | 645.44M | 668.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 841.54M | 655.47M | 614.71M | 645.44M | 668.02M |
|
|
|||||